Accordingly, the control of RBM39 homoeostasis is important for cancer cell survival, and therefore the identification of alternative approaches to lower the intracellular concentration of RBM39 independently of DCAF15 could be beneficial for cancer treatment. This evidence concerns the gene RBM39 and cancer.